The purpose of this study is to evaluate the safety and effectiveness of the ACURATE TAVR system in patient with severe aortic valve stenosis who are identified as an appropriate candidate for the TAVR procedure.

Study the effects of a new drug LY3540378 in patients with heart failure

This study is trying to understand whether ziltivekimab can help patients who have recently had a heart attack.

The aim of the current study is to evaluate the effects of ziltivekimab on heart failure symptoms and physical function in participants with mildly reduced or preserved heart function and evidence of inflammation.

To test if study drug can help improve well being of patients with heart failure

This study is meant to better understand the prevalence of overweight and obesity in patients who have a history of cardiovascular disease.

The purpose of this study is to determine if a new medication is effective at treating cardiac amyloidosis.

This study is testing a medication called ziltivekmab to see if it can help people with heart failure.

This study is testing eplontersen as a treatment for Cardiac Amyloidosis.

The purpose of this study is to survey patients on their experiences being treated for Severe Aortic Stenosis